Skip to content
  • About
    • What we do
    • Our history
    • Our team
    • Our committees
    • Our partners
    • About genomics
  • Services
    • What we offer
    • Research we’re supporting
  • Tools & resources
    • Search all tools & resources
    • Research ethics & governance
    • Consent & patient support materials
    • Evaluating genomic research & translation
    • Data governance
    • Access our datasets
    • Data capture & standardisation
    • Data analysis & interpretation
    • Workforce education
    • Projects actively recruiting
    • Our publications
    • Our submissions
  • Our project areas
    • Our project areas
    • Genomic implementation projects 2022-2024
    • Genomic information management
    • Clinical genomic practice
    • Genomic literacy, workforce & training
    • Indigenous genomic priorities
    • Genomic diagnostics
    • Evaluating genomic research & translation
    • Australian health system policy & practice
    • Involvement & engagement
  • News & events
    • News
    • Events
    • Personal stories
    • Search news & events
  • Connect with us

New national agency to advance genomic medicine welcomed

Home All news & events News New national agency to advance genomic…
Group of young children with hands clasped together in the air

Australian Genomics Lead Professor Kathryn North says a new national agency to support genomic medicine will help propel the integration of genomics into mainstream healthcare, a transformative approach to patient diagnosis and treatment.

She welcomed the announcement by Minister for Health Greg Hunt to invest $28.1 million to establish Genomics Australia from 1 January 2024. The agency will build on six years of work by Australian Genomics.

Professor North will be the inaugural chair of Genomics Australia.

She said its formation was another step towards having genomic medicine as standard of care in Australia, a move that had huge implications for patient welfare.

“Genomic medicine will transform the way we deliver healthcare throughout the life course, enabling rapid diagnosis, prediction, prevention, and personalised therapies,” she said.

“We have worked together across Australia to build a cohesive national approach to translate evidence-based policy in genomics into standard of care within our health system. This is a logical and welcome progression of that work.”

Genomics Australia is expected to become a legislated corporate Commonwealth entity under the Health portfolio. The commonwealth Department of Health will lead its establishment in consultation with consumers, health professionals, researchers and industry.

Mr Hunt said the consultation would ensure strong engagement with Aboriginal and Torres Strait Islander experts, disability and Culturally and Linguistically Diverse groups to ensure their needs were actively included.

State and territory governments will be invited to partner with the Australian Government on the initiative to promote a nationally cohesive approach.

 

Media Contact: Dorothy Illing 0458 549 940